{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:41:48Z","timestamp":1757544108127},"reference-count":28,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jpids\/piy083","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T19:13:39Z","timestamp":1536606819000},"source":"Crossref","is-referenced-by-count":1,"title":["Lemons and Lyme"],"prefix":"10.1093","author":[{"given":"Stanley A","family":"Plotkin","sequence":"first","affiliation":[{"name":"Emeritus Professor of Pediatrics, University of Pennsylvania, Doylestown"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"key\n\t\t\t\t20180913011315_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease - United States, 2008-2015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"key\n\t\t\t\t20180913011315_CIT0002","doi-asserted-by":"crossref","first-page":"s247","DOI":"10.1093\/cid\/ciq115","article-title":"The Lyme disease vaccine--a public health perspective","volume":"52","author":"Shen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0003","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180913011315_CIT0004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180913011315_CIT0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180913011315_CIT0006","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/IAI.65.3.882-889.1997","article-title":"Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi","volume":"65","author":"Golde","year":"1997","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180913011315_CIT0007","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/514779","article-title":"Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine","volume":"28","author":"Van Hoecke","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1473-3099(13)70319-0","article-title":"Lyme disease vaccination: safety first","volume":"14","author":"Stricker","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0009","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t20180913011315_CIT0010","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0011","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(01)00500-X","article-title":"Adverse event reports following vaccination for Lyme disease: December 1998-July 2000","volume":"20","author":"Lathrop","year":"2002","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180913011315_CIT0012","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/art.24418","article-title":"HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination","volume":"60","author":"Ball","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180913011315_CIT0013","doi-asserted-by":"crossref","first-page":"s253","DOI":"10.1093\/cid\/ciq116","article-title":"Vaccines against Lyme disease: what happened and what lessons can we learn","volume":"52","author":"Poland","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0014","doi-asserted-by":"crossref","first-page":"s271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: the need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/vbz.2007.0221","article-title":"Knowledge, attitudes, and behaviors regarding Lyme disease prevention among Connecticut residents, 1999-2004","volume":"8","author":"Gould","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amepre.2009.04.026","article-title":"Peridomestic Lyme disease prevention: results of a population-based case-control study","volume":"37","author":"Connally","year":"2009","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20180913011315_CIT0017","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/infdis\/jiu005","article-title":"Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission","volume":"209","author":"Richer","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(01)00251-1","article-title":"Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine","volume":"20","author":"Straubinger","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180913011315_CIT0019","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/j.vaccine.2005.02.006","article-title":"Multicomponent Lyme vaccine: three is not a crowd","volume":"23","author":"Brown","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180913011315_CIT0020","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CVI.00409-06","article-title":"OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine","volume":"14","author":"Earnhart","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180913011315_CIT0021","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/2049-632X.12119","article-title":"Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C in transmission and infectivity","volume":"70","author":"Earnhart","year":"2014","journal-title":"Pathog Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0022","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1807870","article-title":"Tickborne diseases - confronting a growing threat","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180913011315_CIT0023","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2017.2127","article-title":"Brave new worlds: the expanding universe of Lyme disease","volume":"17","author":"Stone","year":"2017","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0024","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569","article-title":"Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area","volume":"22","author":"van den Wijngaard","year":"2017","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20180913011315_CIT0025","doi-asserted-by":"crossref","first-page":"s266","DOI":"10.1093\/cid\/ciq118","article-title":"A new approach to a Lyme disease vaccine","volume":"52","author":"Livey","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0026","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(13)70110-5","article-title":"Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase \u00bd trial","volume":"13","author":"Wressnigg","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180913011315_CIT0027","doi-asserted-by":"crossref","first-page":"e0184357","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180913011315_CIT0028","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/peds.108.1.123","article-title":"Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial","volume":"108","author":"Sikand","year":"2001","journal-title":"Pediatrics"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piy083\/25711586\/piy083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T10:49:43Z","timestamp":1604918983000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article\/doi\/10.1093\/jpids\/piy083\/5094865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1093\/jpids\/piy083","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]}}}